Frequently Asked Questions
The global capsule endoscope and workstation market was valued at USD 0.185 Billion in 2022.
The capsule endoscope and workstation market is expected to grow at a CAGR of 16.90% between 2023 and 2030, reaching USD 0.55 Billion in 2030.
Capsule endoscope is the leading segment by material, holding over 43% share in terms of value in 2022.
The small intestine disorder segment governs the demand for capsule endoscopes and workstations worldwide, holding a massive share of over 80% in 2022.
The esophageal disorder segment will post the highest CAGR during the forecast period.
Asia Pacific is fueling the growth of the capsule endoscope and workstation industry, with an over one-third share in 2022.
The top players include Shangxian Minimal Invasive Inc., Chongqing Jinshan Science and Technology Group Co., Anx Robotica, MEDTRONIC PLC., IntroMedic Co.
A comprehensive and trustworthy diagnosis can be made using specialized workstations in conjunction with the capsule endoscope are the major market drivers.
Cost is one of the main barriers preventing the widespread use of capsule endoscopes, and workstations are the major market restraints.
The high Cost of technology and a lack of resources, however, have been significant obstacles in these areas and major opportunities in the capsule endoscope and workstation industry.